Compare

Pure Bioscience, Inc. vs ASP Isotopes Inc. vs Flexible Solutions International Inc vs Arq, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPure Bioscience, Inc.
PURE
ASP Isotopes Inc.
ASPI
Flexible Solutions International Inc
FSI
Arq, Inc.
ARQ
Year ended2026-07-312025-12-312025-12-312025-12-31
Revenue$2.32M$23.85M$38.52M$120.34M
Revenue growth (YoY)+5.3%+475.5%+0.7%+10.4%
Gross margin57.2%14.3%32.6%27.9% (computed)
Operating margin-89.9%-251.2%11.9%-44.0%
Net margin-107.1%-670.2%2.0%-43.7%
Net income-$2.48M-$159.84M$786.9K-$52.61M
EPS (Diluted)-$0.02-$2.11$0.06-$1.27
Operating cash flow-$1.74M-$37.78M$3.78M-$2.73M
Free cash flown/a-$47.43M-$591.7K-$11.31M
Cash & equivalents$569.0K$285.60Mn/a$6.57M
Total assets$1.19M$498.02M$61.83M$230.58M
Total liabilities$7.59M$235.12M$19.00M$62.62M
Shareholders' equity-$6.40M$204.15M$38.91M$167.96M
Return on year-end equityn/a-78.3%2.0%-31.3%
Shares outstanding130.02M111.68M12.72M42.73M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPure Bioscience, Inc.ASP Isotopes Inc.Flexible Solutions International IncArq, Inc.
Latest$2.32M
Ended 2026-07-31
$23.85M
Ended 2025-12-31
$38.52M
Ended 2025-12-31
$120.34M
Ended 2025-12-31
1 year earlier$2.20M
Ended 2025-07-31
$4.14M
Ended 2024-12-31
$38.23M
Ended 2024-12-31
$108.96M
Ended 2024-12-31
2 years earlier$1.96M
Ended 2024-07-31
$433.0K
Ended 2023-12-31
$38.32M
Ended 2023-12-31
$99.18M
Ended 2023-12-31
3 years earlier$1.88M
Ended 2023-07-31
$0
Ended 2022-12-31
$45.84M
Ended 2022-12-31
$102.99M
Ended 2022-12-31
4 years earlier$1.85M
Ended 2022-07-31
n/a$34.42M
Ended 2021-12-31
$100.29M
Ended 2021-12-31